Epistemonikos

24/11/2021

We participated in the evidence-based clinical guidelines elaboration work day, of the Sociedad Chilena de Cirugía Bariátrica y Metabólica, working with their team and other organizations and stakeholders. We specialize in the process to go from to . This is a vital step in the elaboration of clinical guidelines that effectively protect people and optimize health processes. 💪

15/11/2021

Don't miss it! The Global Evidence to Policy Summit , hosted by the World Health Organization (WHO), aims to help countries prepare in the best way possible for events like a new pandemic, using evidence-based strategies and tools. Watch CEO and expert Dr Gabriel Rada, in the panel “Strategies and mechanisms for institutionalizing the use of evidence”.
https://www.e2psummit2021.org/evipnetamericasregionalmeeting

09/11/2021

How to dive into the sea of ​​evidence on and come back to shore with clear answers? and , set out to solve this challenge a little over a year ago, creating the dashboard, which gathers the best available evidence and updates it weekly. This dashboard was recently nominated for the of Fundación Gabo
We are extremely honoured to be considered! 🥳
https://www.epistemonikos.cl/2021/11/08/scientifically-proven-our-analysis-of-treatments-against-covid-19-nominated-for-the-gabo-foundation-2021-award/

07/07/2021

Yesterday the WHO recommended the use of IL-6 inhibitors (tocilizumab and sarilumab) to treat patients with severe and critical COVID-19.
https://www.bmj.com/content/370/bmj.m3379

We are happy to be part of several of the initiatives that reached this same conclusion:

- We are part of the team that conducted a living systematic review used by the WHO in their analysis
https://www.bmj.com/lookup/doi/10.1136/bmj.m2980

- We are also part of the teams that authored: the Cochrane review on this topic
https://doi.org/10.1002/14651858.CD013881

- The PAHO living review
https://iris.paho.org/handle/10665.2/52719

- And the COVID-NMA living review
https://covid-nma.com/

- In early June, the Chilean Ministry of Health Ministerio de Salud Chile made its own recommendations. We Epistemonikos collaborated with them as well, using our L·OVE platform
https://twitter.com/ministeriosalud/status/1404924885172957184?s=20

- And, since February, the living special by Salud con lupa and Epistemonikos places tocilizumab in the category "ready for use"
https://saludconlupa.com/comprbate/cientificamente-comprobado-un-analisis-de-los-tratamientos-mas-usados-contra-el-covid-19/

The pandemic has created an ‘infodemic’ with many redundant as well as low-quality studies. Happily it has also generated international collaborations of a pace and quality never seen before. At Epistemonikos we are proud to be part of many of them.

07/07/2021

A new weekly update of our with Salud con lupa is out, summarising the latest evidence about interventions against https://saludconlupa.com/comprueba/scientifically-proven/

We analyzed the 39 most commonly used covid-19 treatments. To conduct this analysis, we created seven classifications, ranging from “highly effective” to “unsupported by science.”. We will update this information weekly as new scientific evidence becomes available.

30/06/2021

Check out this week’s update to our ‘Scientifically Proven’ with all the latest evidence on treatments against … This week moves up and reaches the category of ‘promising’ in our ranking https://saludconlupa.com/comprueba/scientifically-proven/

We analyzed the 39 most commonly used covid-19 treatments. To conduct this analysis, we created seven classifications, ranging from “highly effective” to “unsupported by science.”. We will update this information weekly as new scientific evidence becomes available.

22/06/2021

Check out this week’s update to our ‘Scientifically Proven’ with all the latest evidence on treatments against https://saludconlupa.com/comprueba/scientifically-proven/

This week moves up to ‘Promising’. And the ‘cocktail’ of antibodies and confirms its place as ‘Ready for us’ in a large group of patients after new input from and other trials.

Finally, the REMAP-CAP trial along with other 19 trials involving a total of more than 15,000 patients, confirm that plays no role in the recovery of patients.

We analyzed the 39 most commonly used covid-19 treatments. To conduct this analysis, we created seven classifications, ranging from “highly effective” to “unsupported by science.”. We will update this information weekly as new scientific evidence becomes available.

15/06/2021

Read our “Scientifically Proven” to find, as usual, the latest available evidence for various treatments https://saludconlupa.com/comprueba/scientifically-proven/

Unfortunately, there’s bad news for 3 of the treatments that were still on race. and move to ‘Unpromising’ after adding new results to the analysis. And moves down to “Inappropriate use” after negative results from the trial.

We analyzed the 39 most commonly used covid-19 treatments. To conduct this analysis, we created seven classifications, ranging from “highly effective” to “unsupported by science.”. We will update this information weekly as new scientific evidence becomes available.

08/06/2021

Check out the new update of our about interventions against , created with Salud con lupa. Another week with good news!
✅ This week, the new monoclonal antibody moves up to the “ready to use” category due to its role in preventing contagion in people at high risk of contagion.
https://saludconlupa.com/comprueba/scientifically-proven/

We analyzed the 39 most commonly used covid-19 treatments. To conduct this analysis, we created seven classifications, ranging from “highly effective” to “unsupported by science.”. We will update this information weekly as new scientific evidence becomes available.

01/06/2021

A new weekly update of our with Salud con lupa is out, summarising the latest evidence about interventions against 👇

✅ This week the good news come from the monoclonal antibodies and : they are "ready to use" in early-stage patients 💪

https://saludconlupa.com/comprueba/scientifically-proven/

We analyzed the 39 most commonly used covid-19 treatments. To conduct this analysis, we created seven classifications, ranging from “highly effective” to “unsupported by science.”. We will update this information weekly as new scientific evidence becomes available.

18/05/2021

This week's update of our 📣 is out! With all the emerging evidence on 39 drugs and treatments for 👇
https://saludconlupa.com/comprueba/scientifically-proven/

We analyzed the 39 most commonly used covid-19 treatments. To conduct this analysis, we created seven classifications, ranging from “highly effective” to “unsupported by science.”. We will update this information weekly as new scientific evidence becomes available.

12/05/2021

'The pandemic is evidence on steroids' says our CEO Dr Gabriel Rada in this Nature article, about how has posed a phenomenal challenge on health professionals, researchers and authorities in need of evidence for their decisions and research
We are proud to see DB and L·OVE💚 featured as tools that 'would save everyone [conducting evidence synthesys] a monumental amount of work' 👇
https://www.nature.com/articles/d41586-021-01246-x

The pandemic stress-tested the way the world produces evidence — and revealed all the flaws.

11/05/2021

This week in our 📣 , the latest evidence on treatments for :
✔️ Good news for , which moves up to the 'ready for use' category in our ranking, following the publication of the preprint with results of the trial
✔️ No such luck for , which moves down to the category of 'neutral' in our ranking following new evidence this week

https://saludconlupa.com/comprueba/scientifically-proven/

We analyzed the 39 most commonly used covid-19 treatments. To conduct this analysis, we created seven classifications, ranging from “highly effective” to “unsupported by science.”. We will update this information weekly as new scientific evidence becomes available.

30/04/2021

Monday May 3rd at 3.15 PM Dr Gabriel Rada will participate on the 🇧🇷 1st Brazilian Congress of Clinical Evidence on , Congresso Brasileiro de Covid, organized by the Faculdade de Medicina da UFMG
Our CEO will be talking about 'Living Evidence' methodologies and our L·OVE💚 Platform.
Register here👇
https://www.even3.com.br/covidcongress2021/

13/04/2021

The new update of our 📣 "Scientifically Proven" is out! Find all the latest evidence for different treatments, right here 👇
https://saludconlupa.com/comprueba/scientifically-proven/

We analyzed the 38 most commonly used covid-19 treatments. To conduct this analysis, we created seven classifications, ranging from “highly effective” to “unsupported by science.”. We will update this information weekly as new scientific evidence becomes available.

07/04/2021

Technology➕ methodological innovation ➕ collaborative work can result in projects like 'Living Evidence' 📑
Health researchers will learn about our methodologies and how to use our L·OVE💚 Platform to optimize their evidence synthesis 💪

https://www.epistemonikos.cl/2021/04/07/living-evidence-project-will-train-european-organisations-to-incorporate-l%C2%B7ove-platform-in-evidence-synthesis-process/

This week was the official launch of ‘Living Evidence’, an international project where Epistemonikos Foundation holds a key role. The project aims to train different European organisations that work on evidence synthesis to support health decision-making, in using tools and methodologies that wi...

07/04/2021

We believe in a fairer and healthier world🌎, where health is a basic human right ✊ In this we renew our commitment to making rigorous, always updated scientific evidence available to health professionals and authorities, to safely inform their decisions in health 💪

23/03/2021

New update on our treatments evidence-based 📣
This week, and have been downgraded in our ranking due to disappointing results from several trials 👇
https://saludconlupa.com/comprueba/scientifically-proven/

We analyzed the 38 most commonly used covid-19 treatments. To conduct this analysis, we created seven classifications, ranging from “highly effective” to “unsupported by science.”. We will update this information weekly as new scientific evidence becomes available.